These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21175569)

  • 1. Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.
    Ward RJ; Pediani JD; Milligan G
    Br J Pharmacol; 2011 Mar; 162(6):1439-52. PubMed ID: 21175569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.
    Ward RJ; Pediani JD; Milligan G
    J Biol Chem; 2011 Oct; 286(43):37414-28. PubMed ID: 21908614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
    Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
    J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function.
    Ellis J; Pediani JD; Canals M; Milasta S; Milligan G
    J Biol Chem; 2006 Dec; 281(50):38812-24. PubMed ID: 17015451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro.
    Yu L; Zhang XY; Zhang J; Zhu JN; Wang JJ
    Cerebellum; 2010 Mar; 9(1):88-95. PubMed ID: 19921532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
    Xu TR; Ward RJ; Pediani JD; Milligan G
    J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orexin OX(1) receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands.
    Xu TR; Ward RJ; Pediani JD; Milligan G
    Biochem J; 2011 Oct; 439(1):171-83. PubMed ID: 21770891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OX1 orexin/hypocretin receptor activation of phospholipase D.
    Jäntti MH; Putula J; Somerharju P; Frohman MA; Kukkonen JP
    Br J Pharmacol; 2012 Feb; 165(4b):1109-23. PubMed ID: 21718304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation.
    Silveyra P; Lux-Lantos V; Libertun C
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E977-85. PubMed ID: 17638707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists.
    Faedo S; Perdonà E; Antolini M; di Fabio R; Merlo Pich E; Corsi M
    Eur J Pharmacol; 2012 Oct; 692(1-3):1-9. PubMed ID: 22796453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling.
    Jäntti MH; Putula J; Turunen PM; Näsman J; Reijonen S; Lindqvist C; Kukkonen JP
    Mol Pharmacol; 2013 Mar; 83(3):621-32. PubMed ID: 23233488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor.
    Takai T; Takaya T; Nakano M; Akutsu H; Nakagawa A; Aimoto S; Nagai K; Ikegami T
    J Pept Sci; 2006 Jul; 12(7):443-54. PubMed ID: 16429482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
    Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
    Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexins/hypocretins: pain regulation and cellular actions.
    Chiou LC; Lee HJ; Ho YC; Chen SP; Liao YY; Ma CH; Fan PC; Fuh JL; Wang SJ
    Curr Pharm Des; 2010; 16(28):3089-100. PubMed ID: 20687883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynein light chain Tctex-type 1 modulates orexin signaling through its interaction with orexin 1 receptor.
    Duguay D; Bélanger-Nelson E; Mongrain V; Beben A; Khatchadourian A; Cermakian N
    PLoS One; 2011; 6(10):e26430. PubMed ID: 22028875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexins stimulate steroidogenic acute regulatory protein expression through multiple signaling pathways in human adrenal H295R cells.
    Ramanjaneya M; Conner AC; Chen J; Stanfield PR; Randeva HS
    Endocrinology; 2008 Aug; 149(8):4106-15. PubMed ID: 18450961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the role of hindbrain orexin-1 receptors in the control of meal size.
    Parise EM; Lilly N; Kay K; Dossat AM; Seth R; Overton JM; Williams DL
    Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1692-9. PubMed ID: 21957165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.
    Malherbe P; Borroni E; Gobbi L; Knust H; Nettekoven M; Pinard E; Roche O; Rogers-Evans M; Wettstein JG; Moreau JL
    Br J Pharmacol; 2009 Apr; 156(8):1326-41. PubMed ID: 19751316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of orexins A and B on expression of orexin receptors and progesterone release in luteal and granulosa ovarian cells.
    Cataldi NI; Lux-Lantos VA; Libertun C
    Regul Pept; 2012 Oct; 178(1-3):56-63. PubMed ID: 22749989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.